2A Pharma ApS news
On December 12, 2021, it has been five years since 2A Pharma was founded.
This is a good time to look back and be proud of what we’ve accomplished. Watch the video to see the highlights of the past 5 years.
The virtual 34th International Papillomavirus Conference took place last week, from November 15-19. The conference’s theme this year was: ‘Research and education for HPV elimination’.
Jeanettes E-Poster ‘A Candidate Broadly Protective HPV-Vaccine Targeting the L2 Minor Protein Demonstrates Promising Results in a Clinical Phase I Trial’ was selected for the ‘Featured E-posters’ section (no. 97), as part of the confe
On November 4, Jeanette Prangsgaard held a presentation at the ‘Clinical Trials’ even, organised by Synapse – Life Science Connect Aalborg.
Jeanette spoke about clinical trials, what they entail, and what her role is in the process of the development of our prophylactic HPV vaccine, to pique the interest of students and recent graduates.
The aim of the event is to bridge the gap between academia and the life sciences industry as well as to show students and r
All volunteers have now received three doses of 2AP01 (AAVLP-HPV), our very broad spectrum HPV vaccine formulated without adjuvant. The vaccine is well tolerated and no serious adverse events (SAEs)have been observed to date.